What is the Abdominal Aortic Aneurysm Treatment Market?
What is the Abdominal Aortic Aneurysm?
Aneurysms that occur in the section of the aorta that runs through the abdomen (abdominal aorta) are called abdominal aortic aneurysms (Abdominal Aortic Aneurysm). The portion of the aorta that lies deep inside the abdomen, right in front of the spine, is called the abdominal aorta. Over time, artery walls may become weak and widen. The pressure of blood pumping through the aorta may then cause this weak area to bulge outward, like a balloon (called an aneurysm).
An Abdominal Aortic Aneurysm occurs when this type of vessel weakening happens in the portion of the aorta that runs through the abdomen. The majority of Abdominal Aortic Aneurysms result from atherosclerosis, a chronic degenerative disease of the artery wall, in which fat, cholesterol, and other substances build up in the walls of arteries and form soft or hard deposits called plaques. Abdominal Aortic Aneurysm typically develop slowly over a period of many years and hardly ever cause any noticeable symptoms. Occasionally, especially in thin patients, a pulsating sensation in the abdomen may be felt. The larger an aneurysm grows, the greater the chance it will burst or rupture.
People who have this type of aneurysm do not notice it usually, and this is because it typically does not cause any symptoms. Abdominal Aortic Aneurysm may be detected incidentally or at the time of rupture. An arterial aneurysm is defined as a permanent localized dilatation of the vessel at least 150% compared to a relative normal adjacent diameter of that artery.
Click here to know about the Market Size of the report @ Abdominal Aortic Aneurysm Market Size
Who are the leading companies in the Abdominal Aortic Aneurysm Market Landscape?
Some of the key players of the Abdominal Aortic Aneurysm Market includes Endologix LLC, Cardinal Health, Cook Medical, W. L. Gore & Associates Inc., Medtronic, MicroPort Scientific Corporation, Artivion, Inc., Lifetech Scientific (Shenzhen) Co., Ltd., Lombard Medical, Endologix LLC, Latecba SA, Nectero Medical, Cardiatis, SA, Hangzhou Endonom Medtech Co., Ltd., and others.
What about the Abdominal Aortic Aneurysm Treatment Market?
Currently, there is no drug therapy to limit the progression of Abdominal Aortic Aneurysm. As an aneurysm grows in size, the aorta wall becomes weaker and weaker, which means surgical intervention may be needed. The goal of any treatment strategy is to prevent the rupture of an aneurysm by controlling its growth. If a large Abdominal Aortic Aneurysm is detected before it ruptures, most people will be advised to have treatment to prevent it from rupturing.
If the aneurysm is less than 5 cm or 2 inches, the doctor might try to treat it with medication first. They might prescribe drugs, such as beta-blockers and calcium channel blockers, to lower the blood pressure and relax the blood vessels. These medications will lessen the chance of rupture of aneurysm. Indeed, several therapeutic effects of pharmacological agents have been reported in experimental models, and some agents have undergone Abdominal Aortic Aneurysm clinical trials. Treatment with statins, angiotensin-converting enzyme inhibitors, antibiotics, and anti-inflammatory agents appears to inhibit the growth rate of Abdominal Aortic Aneurysm in humans.
What are the key strengths of Abdominal Aortic Aneurysm Market Report?
Key strengths of Abdominal Aortic Aneurysm Market Report are 11 Years Forecast, 7MM Coverage, Epidemiology Segmentation, Market Size, Drug Uptake, Pipeline Therapies, Market Drivers and Market Barriers.
Which country is expected to account for the most significant prevalent cases for Abdominal Aortic Aneurysm in the 7MM?
The US is expected to account for the highest Abdominal Aortic Aneurysm prevalent cases.
What is the Abdominal Aortic Aneurysm Market Outlook?
The market size of Abdominal Aortic Aneurysm in the 7MM is estimated to be USD 1,579.9 million in 2021, which is further expected to increase by 2032.
The United States holds the largest market share of the Abdominal Aortic Aneurysm among the 7MM countries. In 2021, the market size of Abdominal Aortic Aneurysm in the US was USD 1,065.7 million.
In 2021, among the EU-5 countries, Germany had the highest market share, followed by France and the UK.
Japan holds the smallest share of the 7MM Abdominal Aortic Aneurysm market with a market size of USD 137.8 million in 2021 that is expected to increase by 2032.
Keen to know more about the key players of the report @ Abdominal Aortic Aneurysm Market Companies
Trending Market Research Reports Provided by DelveInsight
1. Technical Due Diligence Firms
6. B-Cell Maturation Antigen Targeted Therapies Market
8. Oncolytic Virus Cancer Therapy Pipeline
10. Phenylketonuria PKU Market
11. Progressive Supranuclear Palsy Market
12. Tay-Sachs Disease Market | Tay-Sachs Market
14. Gene Therapy In CNS Disorder Market
15. Hypertrophic Cardiomyopathy Market
16. Varicella Zoster (HHV-3) Infections Market
19. B Cell Chronic Lymphocytic Leukemia Market
20. Complex Regional Pain Syndrome Market
21. Familial Adenomatous Polyposis Market
22. Familial Lipoprotein Lipase Deficiency Market
23. Metastatic Merkel Cell Carcinoma Market
24. Nephropathic Cystinosis Market
25. Nocturia Market
26. Non-Muscle Invasive Bladder Cancer Market
27. Opioid-related Disorders Market
28. Parainfluenza Virus Infection Market
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Contact Us
Yash Bhardwaj
info@delveinsight.com
Comments
Post a Comment